Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
1.785
-0.205 (-10.30%)
At close: Apr 1, 2025, 4:00 PM
1.850
+0.065 (3.64%)
After-hours: Apr 1, 2025, 7:31 PM EDT

Prime Medicine Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-195.88-198.13-121.82-165.37-3.41
Upgrade
Depreciation & Amortization
6.134.652.220.570.04
Upgrade
Loss (Gain) From Sale of Assets
-0.030.01--
Upgrade
Asset Writedown & Restructuring Costs
---12.02-
Upgrade
Loss (Gain) From Sale of Investments
-2.61-1.037.881.11-10.87
Upgrade
Stock-Based Compensation
26.0713.916.461.750.39
Upgrade
Other Operating Activities
12.3612.518.8384.678.14
Upgrade
Change in Accounts Payable
-5.269.142.461.190.25
Upgrade
Change in Unearned Revenue
70.31----
Upgrade
Change in Other Net Operating Assets
-33.98-6.49-37.8629.99-0.09
Upgrade
Operating Cash Flow
-122.87-165.41-131.83-34.08-5.54
Upgrade
Capital Expenditures
-7.29-8.72-16.1-4.15-0.64
Upgrade
Investment in Securities
74.7527.61-30.34-68.98-
Upgrade
Other Investing Activities
1-0.17-0.67-0.5-0.42
Upgrade
Investing Cash Flow
68.4618.71-47.1-73.63-1.06
Upgrade
Issuance of Common Stock
171.080.66185.54--
Upgrade
Other Financing Activities
24.8--4.04-1.09-0.02
Upgrade
Financing Cash Flow
195.880.66181.49269.2834.93
Upgrade
Net Cash Flow
141.47-146.052.57161.5728.33
Upgrade
Free Cash Flow
-130.16-174.14-147.92-38.23-6.18
Upgrade
Free Cash Flow Margin
-4363.36%----118.68%
Upgrade
Free Cash Flow Per Share
-1.10-1.91-4.37-2.95-2.34
Upgrade
Levered Free Cash Flow
-114.57-96.21-117.62-6.8-6.19
Upgrade
Unlevered Free Cash Flow
-114.57-96.21-117.62-6.8-6.19
Upgrade
Change in Net Working Capital
12.93-13.5137.37-47.845.41
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q